Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2003 Sep 11;309(8018):933–935. doi: 10.1016/S0140-6736(77)92227-9

RAISED URINARY FIBRIN-DEGRADATION PRODUCTS, COMPLEMENT, AND IgG DURING AN INFLUENZA-LIKE ILLNESS

L Fananapazir 1, Elizabeth Edmond 1, Maureen Eccleston 1, JL Anderton 1
PMCID: PMC7135692  PMID: 67390

Abstract

Urine from eight normal controls in whom an influenza-like illness developed contained high concentrations of fibrin-degradation products (F.D.P.), IgG, and C3. The study was carried out when influenza A was prevalent in the community. However, a wide range of serological investigations revealed no evidence for influenza A or other viruses. The infection may have been caused by other viruses which produce upper-respiratory-tract infections and which are not readily diagnosed by serology. Urinary fibrin-degradation products are a well-known marker of glomerulonephritic activity and viral antigens may have induced an immune-complex glomerulonephritis in the 8 controls in whom an influenza-like disease developed. A larger normal population should be investigated during a virus epidemic.

References

REFERENCES

  • 1.Oldstone M.B.A., Dixon F.J. J. exp. Med. 1969;129:483. doi: 10.1084/jem.129.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Henson J.B., Gorham J.R., Tanaka Y., Padgett G.A. Lab. Invest. 1968;19:153. [Google Scholar]
  • 3.Porter D.D., Larsen A., Porter H. J. exp. Med. 1969;130:575. doi: 10.1084/jem.130.3.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sun S.C., Burch B., Sohal R., Chu K. Proc. Soc. exp. Biol. Med. 1967;126:882. doi: 10.3181/00379727-125-32037. [DOI] [PubMed] [Google Scholar]
  • 5.Wright N.G., Morrison W.I., Thomson H., Cornwell H.J.C. Br. J. exp. Path. 1973;54:628. [PMC free article] [PubMed] [Google Scholar]
  • 6.Oldstone M.B.A., Dixon F.J. J. exp. Med. 1971;134:325. [PMC free article] [PubMed] [Google Scholar]
  • 7.Yuceoglu A.M., Berkovich S., Minkowitz S. J. Pediat. 1966;69:603. doi: 10.1016/s0022-3476(66)80047-1. [DOI] [PubMed] [Google Scholar]
  • 8.Burch G.E., Cokolough H.L. Ann. intern. Med. 1969;71:963. doi: 10.7326/0003-4819-71-5-963. [DOI] [PubMed] [Google Scholar]
  • 9.Minkowitz S., Wenk R., Friedman E., Yuceoglu A.M., Berkovich S. Am. J. Med. 1968;44:489. doi: 10.1016/0002-9343(68)90120-4. [DOI] [PubMed] [Google Scholar]
  • 10.Wilson C.B., Dixon F.J. Clin. Immun. 1973;2:121. doi: 10.1016/0090-1229(73)90042-1. [DOI] [PubMed] [Google Scholar]
  • 11.McKay D.G., Margaretten W. Archs intern. Med. 1967;120:129. [PubMed] [Google Scholar]
  • 12.Davison A.M., Thomson D., Robson J.S. Br. med. J. 1973;i:654. doi: 10.1136/bmj.1.5854.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wilson C.B., Smith R.C. Ann. intern. Med. 1972;76:91. doi: 10.7326/0003-4819-76-1-91. [DOI] [PubMed] [Google Scholar]
  • 14.Clarkson A.R., MacDonald A.K., Petrie J.J.B., Cash J.D., Robson J.B. Br. med. J. 1971;iii:447. doi: 10.1136/bmj.3.5772.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Merskey C., Kleiner G.J., Johnson A.J. Blood. 1966;28:1. [PubMed] [Google Scholar]
  • 16.Ratnoff O.D., Menzie C. J. Lab. clin. Med. 1951;37:316. [PubMed] [Google Scholar]
  • 17.Hoq M.S., Das P.C. Scand. J. Haemat. 1971;(suppl. 13):101. doi: 10.1111/j.1600-0609.1971.tb01993.x. [DOI] [PubMed] [Google Scholar]
  • 18.Mancini G., Carbonara A.O., Hermans J.F. Immunochemistry. 1965;2:235. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  • 19.Communicable Diseases Scotland: weekly reports 76/14 and 15, C. D. S. Unit, Ruchill Hospital, Glasgow.
  • 20.Hoq M.S., Anderton J.L., Cunningham M., Cash J.D. Br. med. J. 1974;ii:535. doi: 10.1136/bmj.2.5918.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Combes B., Statsny P., Shorey J.O., Eigenbrodt E.H., Barrera A., Hull A.R., Carter N.W. Lancet. 1971;ii:234. doi: 10.1016/s0140-6736(71)92572-4. [DOI] [PubMed] [Google Scholar]
  • 22.Brzosko W.J., Krawczyński K., Nazarewicz T., Morzycka M., Nowosławski A. Lancet. 1974;ii:477. doi: 10.1016/s0140-6736(74)92012-1. [DOI] [PubMed] [Google Scholar]
  • 23.Melnick J.L., Benyesh-Melnick M., Smith K.O., Rapp F. Perspect. Virol. 1965;4:90. [Google Scholar]
  • 24.Schultz I., Bernick M.B., Earle D.P., Jennings R.B. Nephron. 1968;5:329. doi: 10.1159/000179643. [DOI] [PubMed] [Google Scholar]
  • 25.Apostolov K., Spasić P., Bojanić N. Lancet. 1975;i:1271. doi: 10.1016/S0140-6736(75)90609-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Schwartz R.S. New Engl. J. Med. 1975;293:132. doi: 10.1056/NEJM197507172930308. [DOI] [PubMed] [Google Scholar]
  • 27.Panem S., Ordonez N.G., Kirstein W.H., Katz A.I., Spargo B.H. New Engl. J. Med. 1976;295:478. doi: 10.1056/NEJM197608262950903. [DOI] [PubMed] [Google Scholar]

Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES